Cargando…

The Burden of Nocturnal Symptoms in Patients with Chronic Obstructive Pulmonary Disease: Results of a Real-World Survey in the USA

INTRODUCTION: Patients with chronic obstructive pulmonary disease (COPD) often have poor sleep quality and report a worsening of respiratory symptoms during night-time. However, current clinical guidelines for COPD management do not specifically consider nocturnal symptoms when recommending pharmaco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soler, Xavier, Siddall, James, Small, Mark, Stiegler, Marjorie, Bogart, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458814/ https://www.ncbi.nlm.nih.gov/pubmed/35877036 http://dx.doi.org/10.1007/s41030-022-00196-7

Ejemplares similares

Treatment Patterns for Chronic Obstructive Pulmonary Disease (COPD) in the United States: Results from an Observational Cross-Sectional Physician and Patient Survey
por: Mannino, David, et al.
Publicado: (2022)

Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model
por: Bogart, Michael, et al.
Publicado: (2022)

Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
por: Wu, Benjamin, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis: Physician and patient perspectives on the pathway to care from symptom recognition to diagnosis and disease burden
por: Lancaster, Lisa, et al.
Publicado: (2021)

The clinical and economic burden of chronic obstructive pulmonary disease in the USA
por: Guarascio, Anthony J, et al.
Publicado: (2013)

The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD
por: Muñoz, Anna, et al.
Publicado: (2018)

Disease Burden of Mild Asthma: Findings from a Cross-Sectional Real-World Survey
por: Ding, Bo, et al.
Publicado: (2017)

Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma
por: Silver, Jared, et al.
Publicado: (2020)

Elucidating the Real-World Burden of Chronic Rhinosinusitis With Nasal Polyps in Patients in the USA
por: Benson, Victoria S., et al.
Publicado: (2022)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States
por: Bogart, Michael, et al.
Publicado: (2023)

Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population
por: Bogart, Michael, et al.
Publicado: (2019)

Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea
por: Kim, Jin Seok, et al.
Publicado: (2023)

Symptom burden and self-management in persons with chronic obstructive pulmonary disease
por: Bringsvor, Heidi B, et al.
Publicado: (2018)

Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016–2018
por: Grabich, Shannon, et al.
Publicado: (2022)

5610611 REAL-WORLD EVIDENCE CHARACTERIZING THE BURDEN OF DISEASE IN ALPHA AND BETA THALASSEMIA PATIENTS IN THE USA: AN INTERIM ANALYSIS
por: Musallam, K.M., et al.
Publicado: (2023)

Characterizing Real-World Use Of Tiotropium In Asthma In The USA
por: Averell, Carlyne M, et al.
Publicado: (2019)

Medroxyprogesterone improves nocturnal breathing in postmenopausal women with chronic obstructive pulmonary disease
por: Saaresranta, Tarja, et al.
Publicado: (2005)

Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA
por: Barzi, Afsaneh, et al.
Publicado: (2023)

4569 Burden of illness in idiopathic pulmonary fibrosis: A real-world cohort
por: Farrand, Erica, et al.
Publicado: (2020)

Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims
por: BUCK, P. O., et al.
Publicado: (2017)

Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world
por: Wan, Yin, et al.
Publicado: (2015)

Nocturnal sweating—a common symptom of obstructive sleep apnoea: the Icelandic sleep apnoea cohort
por: Arnardottir, Erna Sif, et al.
Publicado: (2013)

Psychosocial and Financial Burden of Therapy in USA Patients with Pulmonary Arterial Hypertension
por: Helgeson, Scott A., et al.
Publicado: (2020)

Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease
por: Bektas, Meryem, et al.
Publicado: (2020)

Real-world treatments and thrombotic events in polycythemia vera patients in the USA
por: Verstovsek, Srdan, et al.
Publicado: (2023)

Real-World Eculizumab Dosing Patterns Among Patients with Paroxysmal Nocturnal Hemoglobinuria in a US Population
por: Cheng, Wendy Y, et al.
Publicado: (2022)

Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea
por: Spicuzza, Lucia, et al.
Publicado: (2022)

Impact of night-time symptoms in COPD: a real-world study in five European countries
por: Price, David, et al.
Publicado: (2013)

Disease Burden and Treatment Patterns of Psoriasis in Russia: A Real-World Patient and Dermatologist Survey
por: Kubanov, Alexey A., et al.
Publicado: (2018)

The Burden of Prudery
por: Bogart, G. Henri
Publicado: (1911)

Relationship Between Episodic Nocturnal Hypercapnia and History of Exacerbations in Patients with Advanced Chronic Obstructive Pulmonary Disease
por: Kitajima, Takamasa, et al.
Publicado: (2022)

The cost–effectiveness of pegcetacoplan in complement treatment-naïve adults with paroxysmal nocturnal hemoglobinuria in the USA
por: Fishman, Jesse, et al.
Publicado: (2023)

24. Economic Burden of Herpes Zoster Among Individuals with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study
por: Ghaswalla, Parinaz, et al.
Publicado: (2020)

An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan
por: Gall, Henning, et al.
Publicado: (2017)

Effect of Nocturnal Oxygen Therapy on Nocturnal Hypoxemia and Sleep Apnea Among Patients With Chronic Obstructive Pulmonary Disease Traveling to 2048 Meters: A Randomized Clinical Trial
por: Tan, Lu, et al.
Publicado: (2020)

The Saudi guidelines for chronic obstructive pulmonary disease: A fresh “Real-World” approach to COPD
por: Hanania, Nicola A.
Publicado: (2014)

Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy
por: Tashkin, Donald P, et al.
Publicado: (2020)

Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort
por: Ruparel, Mamta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6rhk27vfdatr984vg7opknol6b